AMPIVIEW Trademark

Trademark Overview

On Monday, September 6, 2021, a trademark application was filed for AMPIVIEW with the United States Patent and Trademark Office. The USPTO has given the AMPIVIEW trademark a serial number of 97013293. The federal status of this trademark filing is REGISTERED as of Tuesday, October 3, 2023. This trademark is owned by Enzo Life Sciences, Inc.. The AMPIVIEW trademark is filed in the Chemical Products category with the following description:

Reagents for scientific or medical research use, namely, nucleic acid type reagents for in vitro laboratory use
ampiview

General Information

Serial Number97013293
Word MarkAMPIVIEW
Filing DateMonday, September 6, 2021
Status700 - REGISTERED
Status DateTuesday, October 3, 2023
Registration Number7183829
Registration DateTuesday, October 3, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and ServicesReagents for scientific or medical research use, namely, nucleic acid type reagents for in vitro laboratory use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, October 16, 2021
Primary Code001
First Use Anywhere DateThursday, September 15, 2022
First Use In Commerce DateThursday, September 15, 2022

Trademark Owner History

Party NameEnzo Life Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735
Party NameEnzo Life Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735
Party NameEnzo Life Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 3, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, August 31, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 7, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 25, 2023USE AMENDMENT FILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 25, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 29, 2022ASSIGNED TO LIE
Wednesday, November 2, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 2, 2022PETITION TO REVIVE-GRANTED
Wednesday, November 2, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, September 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 15, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 15, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 15, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, March 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 3, 2022NON-FINAL ACTION E-MAILED
Thursday, March 3, 2022NON-FINAL ACTION WRITTEN
Monday, February 28, 2022ASSIGNED TO EXAMINER
Saturday, October 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 9, 2021NEW APPLICATION ENTERED

Related Keywords

ampiview reagents type vitro laboratory acid namely scientific medical research nucleic